MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MH-18-0100024
Dabilife Pharma Private Limited
Dabilife Pharma Private Limited - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹38.43 Lakh
▼ 82% YoY
Net loss · FY 2025
₹22.62 Lakh
Net margin -58.9%
EBITDA · FY 2025
-₹20.7 Lakh
EBITDA margin -53.9%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Dabilife Pharma Private Limited
Data last updated:
Dabilife Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2021PTC359801.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Tejas Ramesh Zaveri and Tejas Champaklal Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 304 – 305 Kailash Tower Chsl Behind Stc Colony N. S. Phadke Marg Andheri East, Mumbai, Maharashtra, India – 400069.
As per the financials filed for FY 2025, the company reported a revenue of ₹38.43 Lakh, a decline of 82% compared to the previous year. For the same year it recorded a net loss of ₹22.62 Lakh (net margin -58.9%) and EBITDA of -₹20.7 Lakh (EBITDA margin -53.9%). Revenue has declined at a compounded annual rate (CAGR) of 64% over three years.
Dabilife Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0100024).
Company details
CIN U51909MH2021PTC359801
Registration Number 359801
Incorporation Date 03 May 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-18-0100024
Recognitions & Rankings of Dabilife Pharma
Contact details
Dabilife Pharma Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressA – 304 – 305 Kailash Tower Chsl Behind Stc Colony N. S. Phadke Marg Andheri East, Mumbai, Maharashtra, India – 400069
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Dabilife Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Dabilife Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dabilife Pharma Private Limited, buy the company report.
Financials of Dabilife Pharma Private Limited
FY 2025 filings availableDabilife Pharma Private Limited reported revenue of ₹38.43 Lakh (down 82% YoY) for FY 2025.
Revenue · FY 2025
₹38.43 Lakh ▼ 82%
Net loss · FY 2025
₹22.62 Lakh margin -58.9%
EBITDA · FY 2025
-₹20.7 Lakh margin -53.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 82%
3 years · compounded
▼ 64%
EBITDA CAGR growth
1 year
▼ 355%
3 years · compounded
▼ 28%
Revenue has declined at a compounded annual rate (CAGR) of 64% over three years, including a 82% fall in the latest year. EBITDA fell 355% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹20.7 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹22.62 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -53.9% | |||
| Net Profit Margin | -58.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Dabilife Pharma Private Limited, buy the company report.
Board of directors of Dabilife Pharma Private Limited
Dabilife Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tejas Ramesh Zaveri Also directs: Nurasyl Lifesciences Private Limited | Director | 13 Feb 2024 | 2 Years 8 Months | Current |
| Tejas Champaklal Shah | Director | 03 May 2021 | 5 Years 5 Months | Current |
Peer comparison
Dabilife Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pay Pharmaceuticals Private Limited | ₹38.57 Lakh (FY 2024) | 3249.0% | Panchkula, Haryana, India | |||
| Dabilife Pharma Private Limitedthis company | ₹38.43 Lakh (FY 2025) | -₹22.62 Lakh | -58.9% | -82.0% | Mumbai, Maharashtra, India | |
| Pharmanet Medical Services Private Limited | ₹38.33 Lakh (FY 2024) | -70.0% | Kollam, Kerala, India | |||
| Cherubic Laboratories Private Limited | ₹38.15 Lakh (FY 2024) | 37.0% | Cuttack, Odisha, India |
To see the full peer comparison of Dabilife Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dabilife Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dabilife Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Dabilife Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Dabilife Pharma Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Tejas Ramesh Zaveri ceased to be Additional Director on 29 Sep 2024.
AGM
Dabilife Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dabilife Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Tejas Ramesh Zaveri ceased to be Additional Director.
Ceased
Nirav Vikram Maniar ceased to be Director.
Appointed
Tejas Ramesh Zaveri was appointed as Director.
Appointed
Tejas Champaklal Shah was appointed as Director.
Incorporation
03 May 2021
Dabilife Pharma Private Limited was registered on 03 May 2021 with Roc Mumbai I & aged 5 years 5 months as per MCA records.
Frequently asked questions
Dabilife Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 May 2021 (5+ years old) and is registered under CIN U51909MH2021PTC359801.
Dabilife Pharma has 2 current directors:
- Tejas Ramesh Zaveri - Director
- Tejas Champaklal Shah - Director
The latest financial statements of Dabilife Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Dabilife Pharma is U51909MH2021PTC359801. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dabilife Pharma was incorporated on 03 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Dabilife Pharma by revenue are Pay Pharmaceuticals Private Limited, Pharmanet Medical Services Private Limited, Cherubic Laboratories Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Tejas Ramesh Zaveri ceased to be Additional Director on 29 Sep 2024. Nirav Vikram Maniar ceased to be Director on 13 Feb 2024. Tejas Ramesh Zaveri was appointed as Director on 13 Feb 2024. Dabilife Pharma has 4 board changes on record in total.
Yes, Dabilife Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-18-0100024).
The registered office of Dabilife Pharma is at A – 304 – 305 Kailash Tower Chsl Behind Stc Colony N. S. Phadke Marg Andheri East, Mumbai, Maharashtra, India – 400069.
Dabilife Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Dabilife Pharma can be reached at its registered office: A – 304 – 305 Kailash Tower Chsl Behind Stc Colony N. S. Phadke Marg Andheri East, Mumbai, Maharashtra, India – 400069.